A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Maria Isabel Fiel(Icahn School of Medicine at Mount Sinai), Elisa Wurmbach(Miller Orthopedic Specialist), Carlo Battiston, Augusto Villanueva(NYU Langone Health), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Gregory Khitrov(Icahn School of Medicine at Mount Sinai), Jordi Bruix(Hospital Clínic de Barcelona), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Weijia Zhang(Shandong University), Samuel Waxman(Icahn School of Medicine at Mount Sinai), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), Sasan Roayaie(White Plains Hospital), Myron Schwartz(Icahn School of Medicine at Mount Sinai)
Cited by 383
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k